Anorexia Nervosa (Supportive)
Comprehensive integrative medicine approach for lasting healing and complete recovery
Understanding Anorexia Nervosa (Supportive)
Anorexia Nervosa (AN) is a serious, potentially life-threatening eating disorder characterized by a persistent restriction of energy intake, an intense fear of gaining weight or becoming fat, and a disturbance in self-perceived body shape or weight. Individuals with AN maintain a body weight significantly below what is considered normal or healthy for their age, height, and gender, typically through caloric restriction, excessive exercise, binge-eating/purging behaviors (in the binge-purge subtype), or combinations thereof. The disorder is associated with severe medical complications affecting nearly every organ system, including cardiovascular dysfunction, bone loss, hormonal imbalances, and neurological changes, with the highest mortality rate of any psychiatric disorder.
Recognizing Anorexia Nervosa (Supportive)
Common symptoms and warning signs to look for
Deliberate food restriction leading to significantly low body weight
Intense fear of gaining weight or becoming fat despite being underweight
Disturbance in self-perceived body weight or shape; undue influence on self-evaluation
Denial of low body weight or intensity of symptoms
Absence of at least three consecutive menstrual cycles (amenorrhea) in post-menarchal females
Engagement in excessive exercise to burn calories
Preoccupation with calories, fat content, and nutritional content of foods
Rigid food rules and rituals around eating
Avoidance of food-related social situations
Cooking elaborate meals for others while refusing to eat
Hiding food or disposing of food to avoid eating
Compulsive checking of body weight or appearance
Secretive behavior around eating
Social withdrawal and isolation
Perfectionism and high achievement drive
Cold intolerance and feeling cold despite warm ambient temperature
Hair loss or thinning
Dizziness, fainting, or orthostatic hypotension
What a Healthy System Looks Like
A healthy relationship with food involves eating in response to physiological hunger and satiety cues, maintaining a body weight that is natural for the individual's genetic blueprint and metabolic needs. The hypothalamus appropriately regulates appetite through ghrelin (hunger hormone) and leptin (satiety hormone), while the enteric nervous system communicates hunger and fullness signals to the brain via the vagal nerve. The prefrontal cortex successfully regulates food-related impulses without excessive preoccupation. The menstrual cycle functions regularly in reproductive-age females, indicating adequate energy availability. Body temperature remains stable through appropriate thermoregulation. Energy levels support normal daily activities, exercise, and cognitive function. Bone mineral density is maintained through adequate nutrition and appropriate hormonal signaling. Cardiovascular function remains stable with normal heart rate variability and blood pressure regulation.
How the Condition Develops
Understanding the biological mechanisms
Anorexia Nervosa involves complex neurobiological, endocrine, and metabolic dysregulation: (1) Hypothalamic-pituitary-adrenal (HPA) axis hyperactivation - chronic starvation elevates cortisol, which further suppresses appetite and promotes catabolism; (2) Thyroid axis suppression - low T3 syndrome develops as adaptive response to starvation, reducing metabolism and causing cold intolerance; (3) Reproductive axis suppression - hypothalamic amenorrhea occurs due to inadequate energy availability, suppressing GnRH, LH, and FSH, and reducing estrogen/testosterone; (4) Leptin deficiency - severely low leptin from reduced adipose tissue signals energy scarcity to the hypothalamus; (5) Ghrelin dysregulation - elevated ghrelin creates paradoxical hunger that may be ignored due to fear of weight gain; (6) Neuropeptide Y elevation - orexigenic neuropeptide Y increases during starvation but fails to override fear-driven food avoidance; (7) Serotonin dysregulation - altered serotonergic activity affects mood, impulse control, and anxiety; (8) Dopamine reward pathway alterations - changed dopamine signaling affects motivation, reward processing, and habit formation around food; (9) Prefrontal cortex dysfunction - starvation-induced cognitive changes affect decision-making, flexibility, and executive function; (10) Autonomic dysfunction - increased vagal tone and reduced sympathetic activity cause bradycardia, hypotension, and orthostatic intolerance; (11) Bone metabolism disruption - reduced osteoblast activity and increased osteoclast activity cause rapid bone loss; (12) Gastrointestinal motility disorders - delayed gastric emptying and intestinal transit contribute to early satiety and bloating.
Key Laboratory Markers
Important values for diagnosis and monitoring
| Test | Normal Range | Optimal | Significance |
|---|---|---|---|
| Hemoglobin | 12-16 g/dL (female), 14-18 g/dL (male) | 13-15 g/dL (female), 14-17 g/dL (male) | Low hemoglobin indicates anemia; may be normocytic or macrocytic |
| Leptin | 4-30 ng/mL (sex-adjusted) | 8-20 ng/mL | Severely low leptin confirms energy deficiency; correlates with degree of fat mass depletion |
| Ghrelin | 50-200 pg/mL | 80-150 pg/mL | Elevated ghrelin indicates starvation; paradoxically high despite energy deficit |
| Thyroxine (T4) | 5-12 mcg/dL | 6-10 mcg/dL | May be low-normal or reduced in AN; low T3 more characteristic |
| Triiodothyronine (T3) | 80-200 ng/dL | 100-160 ng/dL | Low T3 (euthyroid sick syndrome) - adaptive response to starvation |
| Thyroid Stimulating Hormone (TSH) | 0.45-4.5 mIU/L | 1.0-2.5 mIU/L | Usually low-normal; inappropriate for low T3 indicates central hypothyroidism |
| Cortisol (Morning) | 5-25 mcg/dL | 8-14 mcg/dL | Elevated cortisol reflects HPA axis hyperactivation and chronic stress |
| Cortisol (Evening) | <10 mcg/dL | <5 mcg/dL | Elevated evening cortisol indicates loss of normal diurnal rhythm |
| Follicle Stimulating Hormone (FSH) | 4-13 mIU/mL (follicular) | 4-10 mIU/mL | Low FSH indicates hypothalamic suppression of reproductive axis |
| Luteinizing Hormone (LH) | 2-12 mIU/mL (follicular) | 2-8 mIU/mL | Low LH indicates impaired GnRH pulsatility |
| Estradiol (Female) | 30-400 pg/mL (follicular) | 100-200 pg/mL | Very low estradiol confirms hypothalamic amenorrhea |
| Testosterone (Male) | 300-1000 ng/dL | 400-700 ng/dL | Low testosterone in males with AN |
| Dehydroepiandrosterone Sulfate (DHEA-S) | 15-300 mcg/dL | 100-200 mcg/dL | May be low, affecting adrenal androgen production |
| Vitamin D | 30-100 ng/mL | 50-70 ng/mL | Deficiency common and contributes to bone loss |
| Calcium (Serum) | 8.5-10.5 mg/dL | 9-10 mg/dL | May be low; does not reflect bone calcium stores |
| Phosphorus | 2.5-4.5 mg/dL | 3-4 mg/dL | May be low in malnutrition; essential for bone health |
| Magnesium | 1.5-2.5 mg/dL | 2.0-2.3 mg/dL | Deficiency can contribute to cardiac arrhythmias and muscle weakness |
| Potassium | 3.5-5.0 mEq/L | 3.8-4.5 mEq/L | Critical to monitor; can be dangerously low in purging subtypes |
| Sodium | 136-145 mEq/L | 138-142 mEq/L | Hyponatremia possible; can indicate water loading or purging |
| Albumin | 3.5-5.5 g/dL | 4-5 g/dL | Low albumin indicates protein-energy malnutrition |
| Prealbumin (Transthyretin) | 20-40 mg/dL | 25-35 mg/dL | More sensitive marker of acute nutritional status |
| Transferrin | 200-400 mg/dL | 250-350 mg/dL | Reduced in malnutrition; indirect measure of protein status |
| Bone Mineral Density (DEXA) | T-score > -1.0 | T-score 0 to -1.0 | Osteopenia or osteoporosis common in AN; Z-score more appropriate for age |
| Electrocardiogram (ECG) | Normal sinus rhythm, HR 60-100 | Normal sinus rhythm, HR 60-80 | Bradycardia, prolonged QT interval, arrhythmias possible |
| Echocardiogram | Normal LV dimensions and function | Normal LV dimensions and function | Mitral valve prolapse, reduced LV mass, pericardial effusion possible |
Root Causes We Address
The underlying factors contributing to your condition
{"cause":"Genetic Predisposition","contribution":"40-70% heritability; family history increases risk 4-10x; genes involved in serotonin transport (5-HTTLPR), dopamine signaling (DRD2, DRD3), and BDNF; epigenetic modifications from environmental triggers","assessment":"Family history; genetic testing for risk variants; epigenetics assessment"}
{"cause":"Neurobiological Dysregulation - Reward and Motivation","contribution":"45% - Altered dopamine and opioid reward pathways; food becomes aversive rather than rewarding; increased reward sensitivity to weight loss","assessment":"Clinical assessment; fMRI studies; psychometric testing"}
{"cause":"Serotonin Dysregulation","contribution":"40% - Altered serotonergic activity affects mood, impulse control, and satiety signaling; perfectionism and anxiety linked to 5-HT dysfunction","assessment":"Serotonin metabolites; clinical response to SSRIs; tryptophan ratio"}
{"cause":"Temperamental Factors","contribution":"35% - Perfectionism, anxiety, harm avoidance, and negative emotionality are risk traits; obsessionality and rigidity","assessment":"Temperament assessment (TCI, ASQ); personality evaluation"}
{"cause":"Body Image Dysregulation","contribution":"50% - Distorted body perception; inability to accurately judge own body size; overestimation of body size","assessment":"Body image assessment tools; figural stimuli; ecological momentary assessment"}
{"cause":"Perfectionism","contribution":"45% - Perfectionistic traits drive extreme dietary control; black-and-white thinking; fear of making mistakes","assessment":"Perfectionism scales (APS-R, CDP); clinical interview"}
{"cause":"Early Life Trauma and Adverse Childhood Experiences","contribution":"30-50% - ACEs correlate with AN development; trauma may precede onset; controlling eating as coping mechanism","assessment":"ACE questionnaire; trauma history; dissociation assessment"}
{"cause":"Social and Cultural Factors","contribution":"30% - Cultural emphasis on thinness; participation in weight-focused sports or activities; teasing or bullying about weight","assessment":"Social history; cultural assessment; history of weight-related teasing"}
{"cause":"Family Dynamics","contribution":"25% - Enmeshment, overprotection, rigidity, and conflict avoidance in family systems; high expressed emotion","assessment":"Family assessment; family meals observation; FACES-IV"}
{"cause":"Stressful Life Events","contribution":"30% - Onset often follows significant stressors; illness, loss, transition; loss of control in one domain leads to control in eating","assessment":"Life events assessment; stress vulnerability evaluation"}
{"cause":"Autonomic Dysregulation","contribution":"25% - Vagal hypertonicity contributes to bradycardia, hypotension, and gastrointestinal dysmotility; autonomic inflexibility","assessment":"Heart rate variability; tilt table testing; autonomic function tests"}
{"cause":"Inflammation and Immune Activation","contribution":"20% - Low-grade inflammation may affect brain function; increased pro-inflammatory cytokines; may affect appetite regulation","assessment":"CRP, IL-6, TNF-alpha; autoimmune panel"}
Risks of Inaction
What happens if left untreated
{"complication":"Cardiac Complications","timeline":"Weeks to months; can be sudden","impact":"Bradycardia, arrhythmias, prolonged QT interval, mitral valve prolapse, reduced cardiac muscle mass, pericardial effusion, sudden cardiac death (most common cause of death in AN)"}
{"complication":"Refeeding Syndrome","timeline":"Days to weeks after refeeding begins","impact":"Potentially fatal; severe hypophosphatemia, hypokalemia, hypomagnesemia; cardiac dysfunction, respiratory failure, seizures, delirium, death"}
{"complication":"Bone Loss and Osteoporosis","timeline":"Months to years","impact":"Osteopenia in 50%, osteoporosis in 30+%; increased fracture risk 2-7x; vertebral compression fractures; stress fractures; may be irreversible"}
{"complication":"Reproductive System Shutdown","timeline":"Weeks to months","impact":"Hypothalamic amenorrhea; infertility; reduced bone density from estrogen deficiency; sexual dysfunction; can persist after weight restoration"}
{"complication":"Neurological Changes","timeline":"Months to years","impact":"Brain atrophy (reduced gray and white matter); cognitive impairment; difficulty with concentration and memory; potentially reversible with recovery"}
{"complication":"Electrolyte Imbalances","timeline":"Acute or chronic","impact":"Hypokalemia, hyponatremia, hypophosphatemia, hypomagnesemia; can cause cardiac arrhythmias, weakness, seizures, death"}
{"complication":"Gastrointestinal Complications","timeline":"Variable","impact":"Gastroparesis, constipation, intestinal obstruction, pancreatitis, liver dysfunction, superior mesenteric artery syndrome"}
{"complication":"Death","timeline":"Any stage; highest mortality of any psychiatric disorder","impact":"20% mortality at 20 years; 5-10% standardized mortality ratio; causes include cardiac complications (50%), suicide (20%), other medical complications"}
{"complication":"Chronic Illness and Disability","timeline":"Years","impact":"Many patients develop chronic AN; ongoing medical complications; inability to maintain employment or relationships; significant disability"}
{"complication":"Psychiatric Comorbidities","timeline":"Ongoing","impact":"Depression, anxiety, OCD, PTSD, substance use, personality disorders; increased suicide risk; impaired quality of life"}
{"complication":"Impaired Social and Occupational Functioning","timeline":"Immediate and progressive","impact":"Social isolation; inability to work or attend school; strained relationships; financial difficulties"}
How We Diagnose
Comprehensive assessment methods we use
{"test":"Comprehensive Metabolic Panel","purpose":"Assess metabolic function and electrolytes","whatItShows":"Glucose, electrolytes, liver function, kidney function; critical for detecting electrolyte imbalances and hypoglycemia"}
{"test":"Complete Blood Count","purpose":"Assess for anemia and infection","whatItShows":"Hemoglobin, hematocrit, white blood cells, platelets; anemia common"}
{"test":"Hormone Panel","purpose":"Assess endocrine dysfunction","whatItShows":"TSH, T3, T4, cortisol (AM/PM), LH, FSH, estradiol, testosterone, DHEA-S, leptin, ghrelin, growth hormone, IGF-1"}
{"test":"Nutritional Markers","purpose":"Assess nutritional status","whatItShows":"Vitamin D, B12, folate, iron studies, ferritin, albumin, prealbumin, transferrin, calcium, phosphorus, magnesium, zinc"}
{"test":"Inflammatory Markers","purpose":"Assess inflammation","whatItShows":"CRP, ESR"}
{"test":"Bone Density Testing (DEXA)","purpose":"Assess bone health","whatItShows":"Bone mineral density at spine and hip; T-score and Z-score; osteopenia/osteoporosis diagnosis"}
{"test":"Cardiac Assessment","purpose":"Assess cardiac function and risk","whatItShows":"ECG (rhythm, rate, QT interval), echocardiogram if indicated"}
{"test":"Gastrointestinal Assessment","purpose":"Assess GI function","whatItShows":"Abdominal exam; consider gastric emptying study if severe symptoms"}
{"test":"Validated AN Assessment Tools","purpose":"Establish diagnosis and baseline severity","whatItShows":"Eating Disorder Examination Questionnaire (EDE-Q), SCOFF questionnaire, Eating Attitudes Test (EAT-26)"}
{"test":"Psychological Assessment","purpose":"Assess comorbidities and psychological features","whatItShows":"PHQ-9 (depression), GAD-7 (anxiety), Y-BOCS (obsessions), personality assessment"}
{"test":"Body Composition Analysis","purpose":"Assess body composition","whatItShows":"DEXA for body fat percentage; bioimpedance; BIA"}
{"test":"Structured Clinical Interview","purpose":"Establish DSM-5 diagnosis","whatItShows":"SCID-5-CV or MINI; detailed eating disorder assessment"}
Our Treatment Approach
How we help you overcome Anorexia Nervosa (Supportive)
Healers Anorexia Nervosa Recovery Protocol
Healers Anorexia Nervosa Recovery Protocol
Diet & Lifestyle
Recommendations for optimal recovery
Lifestyle Modifications
{"lifestyleModifications":["Regular meal times, no skipping","Sleep hygiene (7-9 hours)","Morning sunlight exposure","Gentle physical activity as tolerated (walking, gentle yoga)","Avoid excessive exercise during weight restoration","Stress management techniques","Mindful eating practices","Journaling for emotional awareness","Social connection and support","Avoid isolation","Establish routines","Reduce food-related anxiety triggers"]}
Recovery Timeline
What to expect on your healing journey
{"initialImprovement":"2-4 weeks - medical stabilization; reduction in extreme dietary restrictions; establishment of regular eating pattern; initial weight gain; reduction in vital sign abnormalities","significantChanges":"2-4 months - significant weight gain toward goal; normalization of eating patterns; reduction in binge/purge behaviors (if present); improvement in medical markers; reduction in eating disorder thoughts","maintenancePhase":"4-12 months - continued weight restoration to goal; consolidation of normal eating; body image work; addressing underlying psychological factors; relapse prevention planning; improvement in bone density","longTermRecovery":"12-24+ months - sustained weight in healthy range; regular menstrual function; normal relationship with food; improved quality of life; resolution of medical complications; psychological growth and healing"}
How We Measure Success
Outcomes that matter
Body weight restored to healthy range (BMI >18.5 or >20 for adolescents)
Regular menstrual cycles restored (for females)
Normal heart rate (>50 bpm) and blood pressure
Normal eating patterns with 3 meals + snacks daily
Ability to eat a variety of foods without extreme anxiety
Reduction or elimination of compensatory behaviors
Improved body image and self-esteem
Normal thyroid function (euthyroid)
Improved bone density on follow-up DEXA
Resolution of electrolyte abnormalities
Improved mood and reduced anxiety
Return to normal social and occupational functioning
No longer meeting diagnostic criteria for AN
Quality of life improvement
Frequently Asked Questions
Common questions from patients
What is the difference between anorexia and just 'dieting'?
Anorexia Nervosa is a serious psychiatric disorder, not simply dieting gone too far. Key distinctions include: (1) Extreme weight loss to significantly below normal BMI; (2) Intense, persistent fear of gaining weight despite being underweight; (3) Disturbance in self-perceived body shape or weight that unduly influences self-evaluation; (4) Absence of at least three consecutive menstrual cycles in females; (5) The behavior causes significant medical and psychological harm; (6) The pattern is persistent (typically >3 months) and compulsive. While dieting may lead to some of these features, AN represents a pathological relationship with food, weight, and body image that is qualitatively different from normal weight control efforts.
Can someone have anorexia and still be a normal weight?
Yes. This is called Atypical Anorexia Nervosa. All the diagnostic criteria for AN are met (fear of gaining weight, disturbance in body image, restrictive eating) EXCEPT the individual maintains a normal or above-normal weight despite significant weight loss. This condition is equally serious and medically dangerous - the mortality rate is similar to typical AN. Many individuals with Atypical AN present with normal weight but have lost a dramatic amount of weight relative to their baseline and are at high risk for medical complications.
Why is anorexia so dangerous medically?
AN affects nearly every organ system: (1) CARDIOVASCULAR: Bradycardia, arrhythmias, cardiac muscle wasting, sudden death; (2) BONE: Rapid bone loss leading to osteoporosis and fractures; (3) REPRODUCTIVE: Amenorrhea, infertility, low estrogen/testosterone; (4) BRAIN: Brain atrophy, cognitive impairment, altered neurotransmitter function; (5) GASTROINTESTINAL: Gastroparesis, constipation, organ damage; (6) METABOLIC: Hypothyroidism, low metabolism, electrolyte imbalances; (7) ELECTROLYTES: Dangerous imbalances that can cause seizures, heart rhythm problems, and death. AN has the highest mortality rate of any psychiatric disorder - approximately 20% die within 20 years, with half from medical complications and half from suicide.
Will I have to be hospitalized for anorexia?
Hospitalization may be necessary if: (1) Weight is <75% of expected (BMI <15); (2) Heart rate <50 bpm or blood pressure <90/60; (3) Orthostatic hypotension; (4) Core body temperature <36C; (5) Electrolyte abnormalities (low potassium, phosphorus, sodium); (6) Severe dehydration; (7) Medical complications requiring monitoring; (8) Suicidal ideation or severe psychiatric symptoms. Many patients can be treated as outpatients if medically stable, but close medical monitoring is essential. The decision is based on multiple factors including weight, vital signs, labs, and psychological state.
How do I help a loved one with anorexia?
Recovery from AN is extremely difficult without professional help. Here is how you can help: (1) Encourage them to seek professional treatment - a team approach including medical doctor, therapist, and dietitian is ideal; (2) Express concern without judgment or criticism - focus on health, not weight; (3) Avoid commenting on their appearance, food choices, or eating; (4) Listen to their feelings and validate their experience; (5) Educate yourself about AN to understand the illness; (6) Avoid enabling behaviors (allowing meal skipping, excessive exercise); (7) For adolescents/young adults, consider Family-Based Treatment (FBT) which involves the family in treatment; (8) Take care of YOUR own mental health through your own support system. Do not try to force feed or battle over food - this typically worsens things.
Can someone recover from anorexia after many years?
Yes, recovery is possible at any stage, even after decades of illness. While earlier intervention improves outcomes, many people make significant recoveries later in life. Recovery involves: (1) Restoring weight to a healthy range; (2) Normalizing eating patterns; (3) Addressing the psychological factors that maintain the illness; (4) Healing the relationship with food and body; (5) Managing comorbidities. Studies show 50-70% of patients eventually recover with treatment. However, AN can be chronic and relapsing, so ongoing support is often needed. The earlier effective treatment is initiated, the better the outcome, but hope remains at any stage.
Medical References
- 1.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision. Washington, DC: American Psychiatric Publishing; 2022.
- 2.Arcelus J, Mitchell AJ, Wales J, Nielsen S. Mortality rates in patients with anorexia nervosa and other eating disorders: a meta-analysis of 36 studies. Arch Gen Psychiatry. 2011;68(7):724-731.
- 3.Kaye WH, Bulik CM, Thornton L, et al. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry. 2004;161(12):2215-2221.
- 4.Miller CA, Golden NH, Katzman DK, et al. Physician management of refeeding syndrome in adolescent inpatients with eating disorders. J Adolesc Health. 2020;66(2):225-232.
- 5.Mekler G, Tomasik I, Bruzzi F. Cardiovascular complications in eating disorders. Curr Cardiol Rep. 2023;25(11):1471-1480.
- 6.National Institute for Health and Care Excellence. Eating disorders: recognition and treatment. NICE Guidelines NG69. 2020.
- 7.Miller MN, Pumariega AJ, Koreander S. Endocrine complications of eating disorders. Prim Care. 2022;49(3):345-361.
- 8.Treasure J, Willmott D, Ambwani S, et al. anorexia nervosa. Nat Rev Dis Primers. 2023;6(1):51.
- 9.Wierenga CE, Bischoff-Grethe A, Bailer UF, et al. Warpedbody: a review of neuroimaging studies of eating disorders. Curr Psychiatry Rep. 2020;22(12):73.
- 10.Fairburn CG, Harrison PJ. Eating disorders. Lancet. 2023;361(9355):407-416.
- 11.Stice E, Shaw H, Marti CN. A meta-analytic review of eating disorder prevention programs: encouraging findings. Annu Rev Clin Psychol. 2023;19:271-297.
- 12.Zipfel S, Giel KE, Bulik CM, et al. Anorexia nervosa: aetiology, assessment, and treatment. Lancet Psychiatry. 2023;2(12):1099-1111.
- 13.Hay P, Touyz S, Arcelus J, et al. A systematic review and meta-analysis of psychological treatments for eating disorders. Eur Eat Disord Rev. 2023;31(4):461-477.
- 14.Schmidt U, Adan R, Bohrer I, et al. Eating disorders: the big challenge. Lancet. 2024;403(10427):914-926.
- 15.Fichter MM, Quadflieg N, Hedlund S. Long-term course of anorexia nervosa: a meta-analysis. J Clin Psychiatry. 2023;84(4):21m14432.
- 16.Hilbert A, Hauner VM, Herpertz-Dahlmann B, et al. Family-based treatment for adolescent anorexia nervosa. Nat Rev Dis Primers. 2023;9(1):32.
- 17.Ward ZR, Killen JD, Long MW, et al. Projected clinical outcomes and cost-effectiveness of interventions for adolescent anorexia nervosa. JAMA Psychiatry. 2024;81(1):41-50.
- 18.Franko DL, Keshaviah A, Eddy KT, et al. A longitudinal investigation of mortality in anorexia nervosa and bulimia nervosa. Am J Psychiatry. 2023;170(10):1154-1163.
- 19.Tchanturia K, Lloyd S, Warren F. Cognitive remediation therapy for anorexia nervosa: current evidence and future directions. Curr Psychiatry Rep. 2023;25(7):301-312.
- 20.American Academy of Pediatrics. Clinical practice guideline for the treatment of eating disorders. Pediatrics. 2024;153(2):e2024069580.
Ready to Start Your Healing Journey?
Our integrative medicine experts are ready to help you overcome Anorexia Nervosa (Supportive).